Skip to main content
Andrew L. Phillips
( out of 80 reviews )

Andrew L. Phillips, MD, MOH

Languages spoken: English, Cantonese

Clinical Locations

Primary Location

Redwood Health Center

1525 West 2100 South
Salt Lake City , UT 84119

South Jordan Health Center

5126 West Daybreak Parkway
South Jordan , UT 84009

Dr. Phillips is an Assistant Professor within the Division of Occupational and Environmental health at the University of Utah (U of U). This includes supporting the Rocky Mountain Center for Occupational and Environmental Health (RMCOEH).

His current academic responsibilities include education and training of Occupational Medicine residents, graduate students, medical students, and other health professionals. He is responsible for teaching Clinical and Behavioral Aspects of Occupational Injuries and Disease (OEHS 6703-001). His teaching and training not only involves residents in a classroom, but also extends to his work within the Occupational Medicine Clinics, and WCF Insurance (the state of Utah’s largest Worker’s Compensation insurer) where he is a physician reviewer. In the clinical setting, Dr. Phillips oversees residents as they perform care for injured workers, pre-employment exams, fitness-for-duty and return-to-work evaluations; during these processes he provides guidance to help with appropriate decision making, as well as establishing effective bedside manners. At WCF Insurance, Dr. Phillips helps coordinate highly innovative rotational opportunities for the residents and medical students in which they have the opportunity to learn how to better serve patients (e.g., by providing information in medical records to facilitate rapid claims payments; participation in and development of injury prevention activities) within the processes of a robust, highly-respected worker’s compensation insurer. Additionally, he provides residents with training and experience in performing physician reviews addressing the utilization of resources, as well as determining the work relatedness of specific injuries or illnesses.

Dr. Phillips’s research interests have included utilizing the vast databases of WCF Insurance, as well as the epidemiology of various respiratory diseases and the efficacy of associated vaccines.

Board Certification

American Board of Preventive Medicine (Occupational Medicine)

Patient Rating

Patients most often describe this doctor as knowledgeable, professional, and attentive. Many comments praise his ability to listen carefully, explain things clearly, and take time to understand concerns, with several noting a respectful and friendly bedside manner. A small number of comments report a negative experience involving feeling rushed or disrespected, and one mentions concern about the assistant/resident interaction.

Generated via Patient Reviews

4.6 /5
( out of 80 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


Dr. Phillips is an Assistant Professor within the Division of Occupational and Environmental health at the University of Utah (U of U). This includes supporting the Rocky Mountain Center for Occupational and Environmental Health (RMCOEH).

His current academic responsibilities include education and training of Occupational Medicine residents, graduate students, medical students, and other health professionals. He is responsible for teaching Clinical and Behavioral Aspects of Occupational Injuries and Disease (OEHS 6703-001). His teaching and training not only involves residents in a classroom, but also extends to his work within the Occupational Medicine Clinics, and WCF Insurance (the state of Utah’s largest Worker’s Compensation insurer) where he is a physician reviewer. In the clinical setting, Dr. Phillips oversees residents as they perform care for injured workers, pre-employment exams, fitness-for-duty and return-to-work evaluations; during these processes he provides guidance to help with appropriate decision making, as well as establishing effective bedside manners. At WCF Insurance, Dr. Phillips helps coordinate highly innovative rotational opportunities for the residents and medical students in which they have the opportunity to learn how to better serve patients (e.g., by providing information in medical records to facilitate rapid claims payments; participation in and development of injury prevention activities) within the processes of a robust, highly-respected worker’s compensation insurer. Additionally, he provides residents with training and experience in performing physician reviews addressing the utilization of resources, as well as determining the work relatedness of specific injuries or illnesses.

Dr. Phillips’s research interests have included utilizing the vast databases of WCF Insurance, as well as the epidemiology of various respiratory diseases and the efficacy of associated vaccines.

Education history

Graduate Training University of Utah School of Medicine M.O.H.
Residency Occupational Medicine - University of Utah School of Medicine Resident
Residency Radiology - University of Utah School of Medicine Resident
Internship Transitional Medicine - Providence Sacred Heart Medical Center & Children’s Hospital Intern
Professional Medical Medicine - University of Southern California M.D.
Undergraduate Psychology - Brigham Young University B.S.

Selected Publications

Journal Article

  1. Yoon SK, Ellsworth GL, Battan-Wraith S, Phillips AL, Fink RV, Griffin J, Rowley EAK, McKell J, Smith AS, Campbell R, Williams J, Ball SW, Zhao H, Warren B, Rousculp MD, Thiese MS (2026). Real-World Effectiveness and Noninferiority Evaluation and Comparison of Messenger RNA-Based and Protein-Based COVID-19 Vaccines: Protocol for the BEEHIVE Randomized Study With a Hybrid Effectiveness Design. JMIR Res Protoc, 15, e80858.
  2. Thiese MS, Claflin S, Allen JA, Phillips A (2025). The Predictive Value of Cardiovascular Disease for Shoulder Injuries in a Retrospective Cohort Study. J Occup Environ Med, 68(6), 489-495.
  3. White EB, Grant L, Mak J, Olsho L, Edwards LJ, Naleway A, Burgess JL, Ellingson KD, Tyner H, Gaglani M, Lutrick K, Caban-Martinez A, Newes-Adeyi G, Duque J, Yoon SK, Phillips AL, Thompson M, Britton A, Flannery B, Fowlkes A (2024). Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022-2023: A Prospective Cohort Study. Clin Infect Dis, 80(4), 893-900.
  4. Mak J, Khan S, Britton A, Rose S, Gwynn L, Ellingson KD, Meece J, Feldstein LR, Tyner H, Edwards LJ, Thiese MS, Naleway A, Gaglani M, Solle N, Burgess JL, Lamberte JM, Shea M, Hunt-Smith T, Caban-Martinez A, Porter C, Wiegand R, Rai R, Hegmann KT, Hollister J, Fowlkes A, Wesley M, Philips AL, Rivers P, Bloodworth R, Newes-Adeyi G, Olsho LEW, Yoon SK, Saydah S, Lutrick K (2024). Association of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination and Reductions in Post COVID Conditions Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in a US Prospective Cohort of Essential Workers. J Infect Dis, 231(3), 665-676.
  5. Yousaf AR, Mak J, Gwynn L, Lutrick K, Bloodworth RF, Rai RP, Jeddy Z, LeClair LB, Edwards LJ, Olsho LEW, Newes-Adeyi G, Dalton AF, Caban-Martinez AJ, Gaglani M, Yoon SK, Hegmann KT, Phillips AL, Burgess JL, Ellingson KD, Rivers P, Meece JK, Feldstein LR, Tyner HL, Naleway A, Campbell AP, Britton A, Saydah S (2025). COVID-19 Vaccination and Odds of Post-COVID-19 Condition Symptoms in Children Aged 5 to 17 Years. JAMA Netw Open, 8(2), e2459672.
  6. Feldstein LR, Ruffin J, Wiegand R, Grant L, Babu TM, Briggs-Hagen M, Burgess JL, Caban-Martinez AJ, Chu HY, Ellingson KD, Englund JA, Hegmann KT, Jeddy Z, Kuntz J, Lauring AS, Lutrick K, Martin ET, Mathenge C, Meece J, Midgley CM, Monto AS, Naleway AL, Newes-Adeyi G, Odame-Bamfo L, Olsho LEW, Phillips AL, Rai RP, Saydah S, Smith N, Tyner H, Vaughan M, Weil AA, Yoon SK, Britton A, Gaglani M (2024). Protection From COVID-19 Vaccination and Prior SARS-CoV-2 Infection Among Children Aged 6 Months-4 Years, United States, September 2022-April 2023. J Pediatric Infect Dis Soc, 14(1).
  7. Hollister J, Porter C, Sprissler R, Beitel SC, Romine JK, Uhrlaub JL, Grant L, Yoo YM, Fowlkes A, Britton A, Olsho LEW, Newes-Adeyi G, Fuller S, Zheng PQ, Gaglani M, Rose S, Dunnigan K, Naleway AL, Gwynn L, Caban-Martinez A, Schaefer Solle N, Tyner HL, Philips AL, Hegmann KT, Yoon S, Lutrick K, Burgess JL, Ellingson KD (2024). Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance. PLoS One, 19(12), e0306953.
  8. Grant L, Whitaker JA, Yoon SK, Lutrick K, Bhargava S, Brown CP, Zaragoza E, Fink RV, Meece J, Wielgosz K, El Sahly H, Hegmann KT, Lowe AA, Southworth A, Tatum T, Ball SW, Levine MZ, Thiese MS, Battan-Wraith S, Barnes J, Phillips AL, Fry AM, Dawood FS, Randomized Assessment of Influenza Vaccine Efficacy Network RAIVEN (2024). Relative Effectiveness and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Versus Egg-Based Inactivated Influenza Vaccine Among Adults Aged 18-64 Years: Results and Experience From a Randomized, Double-Blind Trial. Open Forum Infect Dis, 11(10), ofae559.
  9. Porter C, Lyski ZL, Uhrlaub JL, Ellingson KD, Jeddy Z, Gwynn L, Rivers P, Sprissler R, Hegmann KT, Coughlin MM, Fowlkes AL, Hollister J, LeClair L, Mak J, Beitel SC, Fuller S, Zheng PQ, Vaughan M, Rai RP, Grant L, Newes-Adeyi G, Yoo YM, Olsho L, Burgess JL, Caban-Martinez AJ, Yoon SK, Britton A, Gaglani M, Phillips AL, Thiese MS, Hagen MB, Jones JM, Lutrick K (2024). Evaluating Immunologic and Illness Outcomes of SARS-CoV-2 Infection in Vaccinated and Unvaccinated Children Aged ≥ 5 Years, in a Multisite Longitudinal Cohort. Diseases, 12(8).
  10. Romine JK, Li H, Coughlin MM, Jones JM, Britton A, Tyner HL, Fuller SB, Bloodworth R, Edwards LJ, Etolue JN, Morrill TC, Newes-Adeyi G, Olsho LEW, Gaglani M, Fowlkes A, Hollister J, Bedrick EJ, Uhrlaub JL, Beitel S, Sprissler RS, Lyski Z, Porter CJ, Rivers P, Lutrick K, Caban-Martinez AJ, Yoon SK, Phillips AL, Naleway AL, Burgess JL, Ellingson KD (2023). Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES-RECOVER Prospective Cohort Study. Clin Infect Dis, 79(1), 96-107.
  11. Rivers P, Porter C, LeClair LB, Jeddy Z, Fowlkes AL, Lamberte JM, Herder K, Smith M, Rai R, Grant L, Hegmann KT, Jovel K, Vaughan M, Mathenge C, Phillips AL, Khan S, Britton A, Pilishvili T, Burgess JL, Newes-Adeyi G, Gaglani M, Caban-Martinez A, Yoon S, Lutrick K, PROTECT network (2024). Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study. Vaccine, 42(7), 1512-1520.
  12. Feldstein LR, Britton A, Grant L, Wiegand R, Ruffin J, Babu TM, Briggs Hagen M, Burgess JL, Caban-Martinez AJ, Chu HY, Ellingson KD, Englund JA, Hegmann KT, Jeddy Z, Lauring AS, Lutrick K, Martin ET, Mathenge C, Meece J, Midgley CM, Monto AS, Newes-Adeyi G, Odame-Bamfo L, Olsho LEW, Phillips AL, Rai RP, Saydah S, Smith N, Steinhardt L, Tyner H, Vandermeer M, Vaughan M, Yoon SK, Gaglani M, Naleway AL (2024). Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years. JAMA, 331(5), 408-416.
  13. Herring MK, Romine JK, Wesley MG, Ellingson KD, Yoon SK, Caban-Martinez AJ, Meece J, Gaglani M, Grant L, Olsho LEW, Tyner HL, Naleway AL, Khan SM, Phillips AL, Solle NS, Rose S, Mak J, Fuller SB, Hunt A, Kuntz JL, Beitel S, Yoo YM, Zheng PQ, Arani G, Lamberte JM, Edwards T, Thompson MG, Sprissler R, Thornburg NJ, Lowe AA, Pilishvili T, Uhrlaub JL, Lutrick K, Burgess JL, Fowlkes AL (2022). Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses. Clin Infect Dis, 76(10), 1822-1831.
  14. Ellingson KD, Hollister J, Porter CJ, Khan SM, Feldstein LR, Naleway AL, Gaglani M, Caban-Martinez AJ, Tyner HL, Lowe AA, Olsho LEW, Meece J, Yoon SK, Mak J, Kuntz JL, Solle NS, Respet K, Baccam Z, Wesley MG, Thiese MS, Yoo YM, Odean MJ, Miiro FN, Pickett SL, Phillips AL, Grant L, Romine JK, Herring MK, Hegmann KT, Lamberte JM, Sokol B, Jovel KS, Thompson MG, Rivers P, Pilishvili T, Lutrick K, Burgess JL, Midgley CM, Fowlkes AL (2023). Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers. Emerg Infect Dis, 29(3), 599-604.
  15. HEROES-RECOVER Network, Thompson MG, Yoon SK, Naleway AL, Meece J, Fabrizio TP, Caban-Martinez AJ, Burgess JL, Gaglani M, Olsho LEW, Bateman A, Lundgren J, Grant L, Phillips AL, Groom HC, Stefanski E, Solle NS, Ellingson K, Lutrick K, Dunnigan K, Wesley MG, Guenther K, Hunt A, Mak J, Hegmann KT, Kuntz JL, Bissonnette A, Hollister J, Rose S, Morrill TC, Respet K, Fowlkes AL, Thiese MS, Rivers P, Herring MK, Odean MJ, Yoo YM, Brunner M, Bedrick EJ, Fleary DE, Jones JT, Praggastis J, Romine J, Dickerson M, Khan SM, Lamberte JM, Beitel S, Webby RJ, Tyner HL (2022). Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers. JAMA, 328(15), 1523-1533.
  16. Lutrick K, Fowlkes A, Rivers P, Herder K, Santibanez TA, LeClair L, Groover K, Lamberte JM, Grant L, Odame-Bamfo L, Ferraris MV, Phillips AL, Sokol B, Lowe AA, Mathenge C, Pubillones FA, Cottam B, McLeland-Wieser H, Jovel KS, Ochoa JS, Mckell J, Berry M, Khan S, Solle NS, Rai RP, Nakayima FM, Newes-Adeyi G, Porter C, Baccam Z, Ellingson KD, Burgess JL, Gaglani M, Gwynn L, Caban-Martinez A, Yoon S (2022). Parental Intentions and Perceptions Toward COVID-19 Vaccination Among Children Aged 4 Months to 4 Years - PROTECT Cohort, Four States, July 2021-May 2022. MMWR Morb Mortal Wkly Rep, 71(35), 1109-1114.
  17. Burns J, Rivers P, LeClair LB, Jovel KS, Rai RP, Lowe AA, Edwards LJ, Khan SM, Mathenge C, Ferraris M, Kuntz JL, Lamberte JM, Hegmann KT, Odean MJ, McLeland-Wieser H, Beitel S, Odame-Bamfo L, Schaefer Solle N, Mak J, Phillips AL, Sokol BE, Hollister J, Ochoa JS, Grant L, Thiese MS, Jacoby KB, Lutrick K, Pubillones FA, Yoo YM, Rentz Hunt D, Ellingson K, Berry MC, Gerald JK, Lopez J, Gerald LB, Wesley MG, Krupp K, Herring MK, Madhivanan P, Caban-Martinez AJ, Tyner HL, Meece JK, Yoon SK, Fowlkes AL, Naleway AL, Gwynn L, Burgess JL, Thompson MG, Olsho LE, Gaglani M (2022). Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT): Protocol for a Multisite Longitudinal Cohort Study. JMIR Res Protoc, 11(7), e37929.
  18. Veguilla V, Fowlkes AL, Bissonnette A, Beitel S, Gaglani M, Porucznik CA, Stockwell MS, Tyner HL, Naleway AL, Yoon SK, Caban-Martinez AJ, Wesley MG, Duque J, Jeddy Z, Stanford JB, Daugherty M, Dixon A, Burgess JL, Odean M, Groom HC, Phillips AL, Schaefer-Solle N, Mistry P, Rolfes MA, Thompson M, Dawood FS, Meece J (2022). Detection and Stability of SARS-CoV-2 in Three Self-Collected Specimen Types: Flocked Midturbinate Swab (MTS) in Viral Transport Media, Foam MTS, and Saliva. Microbiol Spectr, 10(3), e0103322.
  19. Naleway AL, Grant L, Caban-Martinez AJ, Wesley MG, Burgess JL, Groover K, Gaglani M, Yoon SK, Tyner HL, Meece J, Kuntz JL, Yoo YM, Schaefer-Solle N, Olsho LEW, Gerald JK, Rose S, Thiese MS, Lundgren J, Groom HC, Mak J, Louzado Feliciano P, Edwards LJ, Lutrick K, Dunnigan K, Phillips AL, Lamberte JM, Noriega R, Sokol BE, Odean M, Ellingson KD, Smith M, Hegmann KT, Respet K, Dickerson M, Cruz A, Fleary DE, Murthy K, Hunt A, Azziz-Baumgartner E, Gallimore-Wilson D, Harder JA, Odame-Bamfo L, Viergutz J, Arvay M, Jones JM, Mistry P, Thompson MG, Fowlkes AL (2022). Incidence of SARS-CoV-2 infection among COVID-19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January-September 2021. Influenza Other Respir Viruses, 16(3), 585-593.
  20. Fowlkes AL, Yoon SK, Lutrick K, Gwynn L, Burns J, Grant L, Phillips AL, Ellingson K, Ferraris MV, LeClair LB, Mathenge C, Yoo YM, Thiese MS, Gerald LB, Solle NS, Jeddy Z, Odame-Bamfo L, Mak J, Hegmann KT, Gerald JK, Ochoa JS, Berry M, Rose S, Lamberte JM, Madhivanan P, Pubillones FA, Rai RP, Dunnigan K, Jones JT, Krupp K, Edwards LJ, Bedrick EJ, Sokol BE, Lowe A, McLeland-Wieser H, Jovel KS, Fleary DE, Khan SM, Poe B, Hollister J, Lopez J, Rivers P, Beitel S, Tyner HL, Naleway AL, Olsho LEW, Caban-Martinez AJ, Burgess JL, Thompson MG, Gaglani M (2022). Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022. MMWR Morb Mortal Wkly Rep, 71(11), 422-428.
  21. Lutrick K, Groom H, Fowlkes AL, Groover KD, Gaglani M, Rivers P, Naleway AL, Nguyen K, Herring M, Dunnigan K, Phillips A, Parker J, Mayo Lamberte J, Prather K, Thiese MS, Baccam Z, Tyner H, Yoon S (2021). COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine, 40(3), 494-502.
  22. Edwards LJ, Fowlkes AL, Wesley MG, Kuntz JL, Odean MJ, Caban-Martinez AJ, Dunnigan K, Phillips AL, Grant L, Herring MK, Groom HC, Respet K, Beitel S, Zunie T, Hegmann KT, Kumar A, Joseph G, Poe B, Louzado-Feliciano P, Smith ME, Thiese MS, Schaefer-Solle N, Yoo YM, Silvera CA, Mayo Lamberte J, Mak J, McDonald LC, Stuckey MJ, Kutty P, Arvay ML, Yoon SK, Tyner HL, Burgess JL, Hunt DR, Meece J, Gaglani M, Naleway AL, Thompson MG (2021). Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER): Protocol for a Multisite Longitudinal Cohort Study. JMIR Res Protoc, 10(12), e31574.
  23. Thompson MG, Burgess JL, Naleway AL, Tyner H, Yoon SK, Meece J, Olsho LEW, Caban-Martinez AJ, Fowlkes AL, Lutrick K, Groom HC, Dunnigan K, Odean MJ, Hegmann K, Stefanski E, Edwards LJ, Schaefer-Solle N, Grant L, Ellingson K, Kuntz JL, Zunie T, Thiese MS, Ivacic L, Wesley MG, Mayo Lamberte J, Sun X, Smith ME, Phillips AL, Groover KD, Yoo YM, Gerald J, Brown RT, Herring MK, Joseph G, Beitel S, Morrill TC, Mak J, Rivers P, Poe BP, Lynch B, Zhou Y, Zhang J, Kelleher A, Li Y, Dickerson M, Hanson E, Guenther K, Tong S, Bateman A, Reisdorf E, Barnes J, Azziz-Baumgartner E, Hunt DR, Arvay ML, Kutty P, Fry AM, Gaglani M (2021). Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. N Engl J Med, 385(4), 320-329.
  24. Thompson MG, Burgess JL, Naleway AL, Tyner HL, Yoon SK, Meece J, Olsho LEW, Caban-Martinez AJ, Fowlkes A, Lutrick K, Kuntz JL, Dunnigan K, Odean MJ, Hegmann KT, Stefanski E, Edwards LJ, Schaefer-Solle N, Grant L, Ellingson K, Groom HC, Zunie T, Thiese MS, Ivacic L, Wesley MG, Lamberte JM, Sun X, Smith ME, Phillips AL, Groover KD, Yoo YM, Gerald J, Brown RT, Herring MK, Joseph G, Beitel S, Morrill TC, Mak J, Rivers P, Harris KM, Hunt DR, Arvay ML, Kutty P, Fry AM, Gaglani M (2021). Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021. MMWR Morb Mortal Wkly Rep, 70(13), 495-500.
  25. Merris J, Phillips AL, Hegmann KT, Owens JD, Amoafo LA, Thiese MS (2020). Morphine Equivalent Dose-Days (MED-D): Predicting the Impact of Opioid Prescription on Total Workers' Compensation Claim Costs for Acute Low Back Pain. J Occup Environ Med, 62(9), 700-705.
  26. Phillips AL, Thiese MS, Freeman M, Kartchner R, Hegmann KT (2019). Implementation of an Opioid Guideline Impacts on Opioid Prescriptions, Adverse Outcomes, and an Association with a State Opioid-Related Fatalities. J Occup Environ Med, 61(8), 653-658.
  27. Owens JD, Hegmann KT, Thiese MS, Phillips AL (2019). Impacts of Adherence to Evidence-Based Medicine Guidelines for the Management of Acute Low Back Pain on Costs of Worker's Compensation Claims. J Occup Environ Med, 61(6), 445-452.